NCT01612351 2026-03-17
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
UNC Lineberger Comprehensive Cancer Center
Hoffmann-La Roche
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Changhai Hospital
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
H. Lee Moffitt Cancer Center and Research Institute